rebel Financial rebel Financial
← All Posts
DNA

Ginkgo Bioworks Holdings, Inc.

June 11, 2026 Author: Phil Ratcliff DNA
Item Proposal Vote
1 Election of Class A Directors
1a Ross Fubini ✓ For
1b Christian Henry ✓ For
1c Sri Kosuri ✓ For
1d Harry E. Sloan ✓ For
2 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. ✓ For
3 Advisory vote to approve executive compensation. ✓ For
Attachments
📄
DNA_10k_2025.pdf 17.3 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.